201613_S_AT |
AP1G2 |
adaptor-related protein complex 1, gamma 2 subunit |
202210_X_AT |
GSK3A |
glycogen synthase kinase 3 alpha |
202643_S_AT |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
202869_AT |
OAS1 |
2',5'-oligoadenylate synthetase 1, 40/46kDa |
203055_S_AT |
ARHGEF1 |
Rho guanine nucleotide exchange factor (GEF) 1 |
203317_AT |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
203761_AT |
SLA |
Src-like-adaptor |
204174_AT |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
204958_AT |
PLK3 |
polo-like kinase 3 (Drosophila) |
206513_AT |
AIM2 |
absent in melanoma 2 |
207222_AT |
PLA2G10 |
phospholipase A2, group X |
207292_S_AT |
MAPK7 |
mitogen-activated protein kinase 7 |
209333_AT |
ULK1 |
unc-51-like kinase 1 (C. elegans) |
209826_AT |
EGFL8 |
EGF-like-domain, multiple 8 |
209970_X_AT |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) |
210042_S_AT |
CTSZ |
cathepsin Z |
210107_AT |
CLCA1 |
chloride channel, calcium activated, family member 1 |
211093_AT |
PDE6C |
phosphodiesterase 6C, cGMP-specific, cone, alpha prime |
211965_AT |
ZFP36L1 |
zinc finger protein 36, C3H type-like 1 |
212285_S_AT |
AGRN |
agrin |
213965_S_AT |
CHD5 |
Coronary heart disease, susceptibility to, 5 |
217914_AT |
TPCN1 |
two pore segment channel 1 |
218559_S_AT |
MAFB |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
219113_X_AT |
HSD17B14 |
hydroxysteroid (17-beta) dehydrogenase 14 |
219416_AT |
SCARA3 |
scavenger receptor class A, member 3 |
219418_AT |
NHEJ1 |
nonhomologous end-joining factor 1 |
220114_S_AT |
STAB2 |
stabilin 2 |
220454_S_AT |
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
221107_AT |
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 |
221840_AT |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
33197_AT |
MYO7A |
myosin VIIA |
36742_AT |
TRIM15 |
tripartite motif-containing 15 |